Net Pals Net Pals
Search Results
See All Results
  • Join
    Sign In
    Sign Up
    Search
    Night Mode

Search

Discover new people, create new connections and make new friends

  • News Feed
  • EXPLORE
  • Pages
  • Groups
  • Events
  • Reels
  • Blogs
  • Market
  • Offers
  • Jobs
  • Posts
  • Blogs
  • Users
  • Pages
  • Groups
  • Events
  • sarthak1234 added blog Health
    2026-07-13 10:29:39 - Translate -
    The Future of Cancer Care: How Oncology Therapeutics Are Advancing Patient Outcomes
    Oncology therapeutics have revolutionized cancer care, offering patients a growing arsenal of innovative treatments that are more effective, better tolerated, and more personalized than ever before. From targeted therapies and immunotherapies to novel drug conjugates and gene therapies, these treatments are transforming the way cancer is managed and improving outcomes for patients worldwide....
    0 Comments 0 Shares 49 Views 0 Reviews
    Please log in to like, share and comment!
  • Vanshika04 added blog Health
    2026-05-28 09:01:31 - Translate -
    Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment Opportunities
    The global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...
    0 Comments 0 Shares 961 Views 0 Reviews
    Please log in to like, share and comment!
  • Subhayan2 added blog Other
    2026-06-12 10:21:56 - Translate -
    United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
    The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...
    0 Comments 0 Shares 819 Views 0 Reviews
    Please log in to like, share and comment!
© 2026 Net Pals English
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Terms Privacy Cookies Acceptable Use Contact Us Directory